Isis Reaches New 52-Week High (ISIS)
NEW YORK (
) --
(Nasdaq:
) hit a new 52-week high Friday as it is currently trading at $33.63, above its previous 52-week high of $32.86 with 366,992 shares traded as of 10:45 a.m. ET. Average volume has been 1.7 million shares over the past 30 days.
Isis has a market cap of $3.59 billion and is part of the health care sector and drugs industry. Shares are up 203.6% year to date as of the close of trading on Thursday.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Isis
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. You can view the full
.
See all
52-week high stocks
or get investment ideas from our
.
.
null